Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase/c-Jun-mediated Bcl-2 gene expression and protein translocation

Journal of Orthopaedic Research

Volumn 25, Issue 5, 2007, Pages 625-635

  Tai, Yu Ting ^a,b   Cherng, Yih Giun ^b   Chang, Chia Chen ^a,b   Hwang, Yi Ping ^a,b   Chen, Jui Tai ^a   Chen, Ruei Ming ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bcl 2; JNK c Jun activation; Nitric oxide; Osteoblasts; Protection

Indexed keywords

ALKALINE PHOSPHATASE; MESSENGER RNA; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOPLASM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; IMAGE ANALYSIS; MITOCHONDRION; MOLECULAR MECHANICS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; OSTEOBLASTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKULL;

EID: 34248332630     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20365     Document Type: Article

References (36)

1. Evans DM, Ralston SH. 1996. Nitric oxide and bone. J Bone Miner Res 11:300-305.
2. Collin-Osdoby P, Nickols GA, Osdoby P. 1995. Bone cell function, regulation, and communication: a role for nitric oxide. J Cell Biochem 57:399-408.
3. Van't Hof RJ, MacPhee J, Libouban H, et al. 2004. Regulation of bone mass and bone turnover by neuronal nitric oxide synthase. Endocrinology 145:5068-5074.
4. Aguirre J, Buttery L, O'Shaughnessy M, et al. 2001. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathol 158:247-257.
5. Chen RM, Chen TL, Chiu WT, et al. 2005. Molecular mechanism of nitric oxide-induced osteoblast apoptosis. J Orthop Res 23:462-468.
6. Damoulis PD, Hauschka PV. 1997. Nitric oxide acts in conjunction with proinflammatory cytokines to promote cell death in osteoblasts. J Bone Miner Res 12:412-422.
7. Ho WP, Chen TL, Chiu WT, et al. 2005. Nitric oxide induced osteoblast apoptosis through a mitochondrial-dependent pathway. Ann NY Acad Sci 1042:460-470.
8. Armour KE, Van't Hof RJ, Grabowski PS, et al. 1999. Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 14:2137-2142.
9. Riancho JA, Salas E, Zarrabeitia MT, et al. 1995. Expression and functional role of nitric oxide synthase in osteoblast-like cells. J Bone Min Res 10:439-446.
10. MacPherson H, Noble BS, Ralston SH. 1999. Expression and functional role of nitric oxide synthase in osteoblast-like cells. Bone 24:179-185.
11. Torcia M, De Chiara G, Nencioni L, et al. 2001. Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release. J Biol Chem 276:39027-39036.
12. Zeini M, Hortelano S, Traves PG, et al. 2005. Assessment of a dual regulatory role for NO in liver regeneration after partial hepatectomy: protection against apoptosis and retardation of hepatocyte proliferation. FASEB J 19:995-997.
13. Cottart CH, Do L, Blanc MC, et al. 1999. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology 29:809-813.
14. Armour KE, Ralston SH. 1998. Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 139:799-802.
15. Bai XC, Lu D, Bai J, et al. 2004. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochem Biophys Res Commun 314:197-207.
16. Chen RM, Liu HC, Lin YL, et al. 2002. Nitric oxide induces osteoblast apoptosis through the de novo synthesis of Bax protein. J Orthop Res 20:295-302.
17. Chang CC, Liao YS, Lin YL, et al. 2006. Nitric oxide protects osteoblasts from oxidative stress-induced apoptotic insults via a mitochondria-dependent mechanism. J Orthop Res 24:1917-1925.
18. Wei MC, Zong WX, Cheng EH, et al. 2001. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730.
19. Luo X, Budihardjo I, Zou H, et al. 1998. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481-490.
20. Brichese L, Cazettes G, Valette A., 2004. JNK is associated with Bcl-2 and PP1 in mitochondria: paclitaxel induces its activation and its association with the phosphorylated form of Bcl-2. Cell Cycle 3:1312-1319.
21. Gonzalez-Polo RA, Carvalho G, Braun T, et al. 2005. PK11195 potently sensitizes to apoptosis induction independently from the peripheral benzodiazepin receptor. Oncogene 24:7503-7513.
22. Gonzalez A, Martinez-A C, Rebollo A. 1998. IL-2-induced cellular events. Crit Rev Immunol 18:185-220.
23. Liu HC, Chen RM, Jian WC, et al. 2001. Cytotoxic and antioxidant effects of the water extract of traditional Chinese herb Gusuibu (Drynaria fortunei) on rat osteoblasts. J Formos Med Assoc 100:383-388.
24. Chen RM, Chen TL, Lin YL, et al. 2005. Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells through downregulating endothelial nitric oxide synthase expression and intracellular calcium levels. Crit Care Med 33:1044-1049.
25. Chang Y, Chen TL, Chiu WT, et al. 2005. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol 204:27-35.
26. Wu GJ, Tai YT, Chen TL, et al. 2005. Propofol specifically inhibits mitochondrial membrane potential but not complex I NADH dehydrogenase activity thus reducing cellular ATP biosynthesis and migration of macrophages. Ann NY Acad Sci 1042:168-176.
27. Chen RM, Wu CH, Chang HC, et al. 2003. Propofol suppresses macrophage functions through modulating mitochondrial membrane potential and cellular adenosine triphosphate levels. Anesthesiology 98:1178-1185.
28. Yamanaka M, Shirai M, Shiina H, et al. 2002. Loss of antiapoptotic genes in aging rat crura. J Urol 168:2296-2300.
29. Hikiji H, Shin WS, Koizumi T, et al. 2000. Peroxynitrite production by TNF-α and IL-1β: implication for suppression of osteoblastic differentiation. Am J Physiol 278: E1031-E1037.
30. Monastyrskaya E, Folarin N, Malyshev I, et al. 2002. Application of the nitric oxide donor SNAP to cardiomyocytes in culture provides protection against oxidative stress. Nitric Oxide 7:127-131.
31. Yu C, Rahmani M, Almenara J, et al. 2004. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK-and AKT-dependent process. Oncogene 23:1364-1376.
32. Gururajan M, Chui R, Karuppannan AK, et al. 2005. c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells. Blood 106:1382-1391.
33. Zu K, Hawthorn L, Ip C. 2005. Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cells. Mol Cancer Ther 4: 43-50.
34. Eferl R, Wagner EF. 2003. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 3:859-868.
35. Palamarchuk A, Efanov A, Maximov V, et al. 2005. Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 65:11282-11286.
36. Dhandapani KM, Hadman M, De Sevilla L, et al. 2003. Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway. J Biol Chem 278:43329-43339.